Welcome to LookChem.com Sign In|Join Free
  • or
H-VAL-TYR-OH is a tripeptide composed of valine, tyrosine, and hydroxyproline, which are essential and non-essential amino acids that contribute to various physiological functions in the body. Valine is crucial for protein synthesis and muscle tissue maintenance, tyrosine is involved in the production of neurotransmitters and hormones, and hydroxyproline is vital for the stability and structure of collagen in connective tissues. The combination of these amino acids in H-VAL-TYR-OH suggests potential benefits in muscle health, neurotransmission, hormonal regulation, and collagen synthesis.

3061-91-4

Post Buying Request

3061-91-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3061-91-4 Usage

Uses

Used in Pharmaceutical Industry:
H-VAL-TYR-OH is used as a therapeutic agent for muscle maintenance and repair due to its valine content, which is essential for protein synthesis and muscle tissue preservation.
Used in Neurotransmission Applications:
H-VAL-TYR-OH is used as a precursor for neurotransmitter production, particularly due to its tyrosine component, which plays a role in the synthesis of important neurotransmitters and hormones.
Used in Hormone Regulation:
H-VAL-TYR-OH is used as a hormone regulator, leveraging the tyrosine content to support the production and regulation of various hormones in the body.
Used in Collagen Synthesis and Connective Tissue Health:
H-VAL-TYR-OH is used as a collagen stabilizer and promoter of connective tissue health, thanks to its hydroxyproline component, which is essential for the structure and stability of collagen, the primary protein in connective tissues.
Used in Cosmetic Industry:
H-VAL-TYR-OH is used as an ingredient in skincare products to support collagen production and improve skin elasticity and firmness, due to its hydroxyproline content that contributes to collagen synthesis and stability.
Used in Sports Nutrition:
H-VAL-TYR-OH is used as a supplement in sports nutrition to support muscle growth and recovery, taking advantage of its valine component for protein synthesis and muscle tissue maintenance.
Used in Research and Development:
H-VAL-TYR-OH is used as a research tool in the development of new therapeutic agents and supplements targeting muscle health, neurotransmission, hormonal regulation, and connective tissue integrity.

Check Digit Verification of cas no

The CAS Registry Mumber 3061-91-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,0,6 and 1 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 3061-91:
(6*3)+(5*0)+(4*6)+(3*1)+(2*9)+(1*1)=64
64 % 10 = 4
So 3061-91-4 is a valid CAS Registry Number.
InChI:InChI=1/C14H20N2O4/c1-8(2)12(15)13(18)16-11(14(19)20)7-9-3-5-10(17)6-4-9/h3-6,8,11-12,17H,7,15H2,1-2H3,(H,16,18)(H,19,20)/t11-,12-/m0/s1

3061-91-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name H-VAL-TYR-OH

1.2 Other means of identification

Product number -
Other names Angiotensin IV (1-2)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3061-91-4 SDS

3061-91-4Relevant academic research and scientific papers

Angiotensin I-converting enzyme inhibitory peptides in a hydrolyzed chicken breast muscle extract

Saiga, Ai,Okumura, Tomoyuki,Makihara, Toshikazu,Katsuta, Shinichiro,Shimizu, Tsuyoshi,Yamada, Ryoji,Nishimura, Toshihide

, p. 1741 - 1745 (2003)

The blood pressure of spontaneously hypertensive rats (SHRs) decreased after oral administration of an extract prepared from chicken breast muscle, falling maximally to 50 mmHg lower than before. This effect continued for at least 4 h after administration. The peptides possessing hypotensive activity in the chicken extract were examined by measuring the inhibitory activity (IC50) against angiotensin I-converting enzyme (ACE). The inhibitory activity of the chicken extract was 1060 mg%, whereas the activity of the extract treated with an Aspergillus protease and gastric proteases (trypsin, chymotrypsin, and intestinal juice) became stronger, reaching 1.1 mg%. Peptides in this hydrolysate of the extract were isolated by HPLC on a reversed-phase column, and their N-terminal sequences were analyzed. Three peptides possessed a common sequence, Gly-X-X-Gly-X-X-Gly-X-X, which was homologous with that of collagen. The peptide Gly-Phe-Hyp-Gly-Thr-Hyp-Gly-Leu-Hyp-Gly-Phe showed the strongest inhibitory activity (IC50 = 42 μM).

Identification and characterization of prokaryotic dipeptidyl-peptidase 5 from porphyromonas gingivalis

Ohara-Nemoto, Yuko,Rouf, Shakh M. A.,Naito, Mariko,Yanase, Amie,Tetsuo, Fumi,Ono, Toshio,Kobayakawa, Takeshi,Shimoyama, Yu,Kimura, Shigenobu,Nakayama, Koji,Saiki, Keitarou,Konishi, Kiyoshi,Nemoto, Takayuki K.

, p. 5436 - 5448 (2014/03/21)

Porphyromonas gingivalis, a Gram-negative asaccharolytic anaerobe, is a major causative organism of chronic periodontitis. Because the bacterium utilizes amino acids as energy and carbon sources and incorporates them mainly as dipeptides, a wide variety of dipeptide production processes mediated by dipeptidyl-peptidases (DPPs) should be beneficial for the organism. In the present study, we identified the fourth P. gingivalis enzyme, DPP5. In a dpp4-7-11-disrupted P. gingivalis ATCC 33277, a DPP7-like activity still remained. PGN-0756 possessed an activity indistinguishable from that of the mutant, and was identified as a bacterial orthologue of fungal DPP5, because of its substrate specificity and 28.5% amino acid sequence identity with an Aspergillus fumigatus entity. P. gingivalis DPP5 was composed of 684 amino acids with a molecular mass of 77,453, and existed as a dimer while migrating at 66 kDa on SDS-PAGE. It preferred Ala and hydrophobic residues, had no activity toward Pro at the P1 position, and no preference for hydrophobic P2 residues, showed an optimal pH of 6.7 in the presence of NaCl, demonstrated Km and kcat/Km values for Lys-Ala-MCA of 688 μM and 11.02 μM-1 s-1, respectively, and was localized in the periplasm. DPP5 elaborately complemented DPP7 in liberation of dipeptides with hydrophobic P1 residues. Examinations of DPP- and gingipain gene-disrupted mutants indicated that DPP4, DPP5, DPP7, and DPP11 together with Arg- and Lys-gingipains cooperatively liberate most dipeptides from nutrient oligopeptides. This is the first study to report that DPP5 is expressed not only in eukaryotes, but also widely distributed in bacteria and archaea.

Synthesis of a precursor tripeptide Z-Asp-Val-Tyr-OH of thymopentin by chemo-enzymatic method

Zheng, Kun,Shi, Wei,Zhan, Ruiyan,Hong, Yang,Li, Shijun,Li, Jing

, p. 520 - 534,15 (2012/12/12)

The precursor tripeptide of thymopentin was synthesized by a combination of chemical and enzymatic methods. First, Val-Tyr-OH dipeptide was synthesized by a novel chemical method in two steps involving preparation of NCA-Val. Second, the linkage of the third amino acid Z-Asp-OMe to Val-Tyr-OH was completed by an enzymatic method under kinetic control. An industrial alkaline protease alcalase was used in water-organic cosolvent systems. The synthesis reaction conditions were optimized by examining the effects of several factors including organic solvents, water content, temperature, pH, and reaction time on the yield of Z-Asp-Val-Tyr-OH. The optimum condition is of pH 10.0, 35C, acetonitrile/Na 2CO3-NaHCO3 buffer system (85:15, v/v), and reaction time of 2.5hr, which achieves tripeptide yield of more than 70%.

Synthesis of a precursor tripeptide Z-Asp-Val-Tyr-OH of thymopentin by chemo-enzymatic method

Zheng, Kun,Zhan, Ruiyan,Hong, Yang,Li, Jing,Shi, Wei,Li, Shijun

, p. 520 - 534 (2013/01/15)

The precursor tripeptide of thymopentin was synthesized by a combination of chemical and enzymatic methods. First, Val-Tyr-OH dipeptide was synthesized by a novel chemical method in two steps involving preparation of NCA-Val. Second, the linkage of the third amino acid Z-Asp-OMe to Val-Tyr-OH was completed by an enzymatic method under kinetic control. An industrial alkaline protease alcalase was used in water-organic cosolvent systems. The synthesis reaction conditions were optimized by examining the effects of several factors including organic solvents, water content, temperature, pH, and reaction time on the yield of Z-Asp-Val-Tyr-OH. The optimum condition is of pH 10.0, 35C, acetonitrile/Na 2CO3-NaHCO3 buffer system (85:15, v/v), and reaction time of 2.5hr, which achieves tripeptide yield of more than 70%.

Inhibitors of tripeptidyl peptidase II. 2. Generation of the first novel lead inhibitor of cholecystokinin-8-inactivating peptidase: A strategy for the design of peptidase inhibitors

Ganellin, C. Robin,Bishop, Paul B.,Bambal, Ramesh B.,Chan, Suzanne M. T.,Law, James K.,Marabout, Benoit,Luthra, Pratibha Mehta,Moore, Andrew N. J.,Peschard, Olivier,Bourgeat, Pierre,Rose, Christiane,Vargas, Froylan,Schwartz, Jean-Charles

, p. 664 - 674 (2007/10/03)

The cholecystokinin-8 (CCK-8)-inactivating peptidase is a serine peptidase which has been shown to be a membrane-bound isoform of tripeptidyl peptidase II (EC 3.4.14.10). It cleaves the neurotransmitter CCK-8 sulfate at the Met-Gly bond to give Asp-Tyr(SO3H)-Met-OH + Gly-Trp-Met-Asp-Phe-NH2. In seeking a reversible inhibitor of this peptidase, the enzymatic binding subsites were characterized using a fluorimetric assay based on the hydrolysis of the artificial substrate Ala-Ala-Phe-amidomethylcoumarin. A series of di- and tripeptides having various alkyl or aryl side chains was studied to determine the accessible volume for binding and to probe the potential for hydrophobic interactions. From this initial study the tripeptides Ile-Pro-Ile-OH (K(i) = 1 μM) and Ala-Pro-Ala-OH (K(i) = 3 μM) and dipeptide amide Val-Nvl-NHBu (K(i) = 3 μM) emerged as leads. Comparison of these structures led to the synthesis of Val-Pro-NHBu (K(i) = 0.57 μM) which served for later optimization in the design of butabindide, a potent reversible competitive and selective inhibitor of the CCK-8-inactivating peptidase. The strategy for this work is explicitly described since it illustrates a possible general approach for peptidase inhibitor design.

SYNTHETIC APPROACHES FOR THYMOPENTIN (TP-5) USING THE "IN SITU" SILYLATION STRATEGY WITH TRIMETHYLSILYL CYANIDE

Becu, Fr.,Becu, Chr.,Anteunis, M. J. O.

, p. 15 - 23 (2007/10/02)

The synthesis of the pentapeptide TP-5 has been considered as a test case for the "in situ" silylating strategy, using trimethylsilyl cyanide, because of the nature of the involved residues.Thus orthogonal lateral protections for Arg, Lys and Asp are need

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 3061-91-4